BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31580842)

  • 1. MicroRNA Ratios Distinguish Melanomas from Nevi.
    Torres R; Lang UE; Hejna M; Shelton SJ; Joseph NM; Shain AH; Yeh I; Wei ML; Oldham MC; Bastian BC; Judson-Torres RL
    J Invest Dermatol; 2020 Jan; 140(1):164-173.e7. PubMed ID: 31580842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
    Babapoor S; Horwich M; Wu R; Levinson S; Gandhi M; Makkar H; Kristjansson A; Chang M; Dadras SS
    Mod Pathol; 2016 May; 29(5):461-75. PubMed ID: 26916074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-methylation profiling distinguishes malignant melanomas from benign nevi.
    Conway K; Edmiston SN; Khondker ZS; Groben PA; Zhou X; Chu H; Kuan PF; Hao H; Carson C; Berwick M; Olilla DW; Thomas NE
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):352-60. PubMed ID: 21375697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma.
    Lazova R; Smoot K; Anderson H; Powell MJ; Rosenberg AS; Rongioletti F; Pilloni L; D'Hallewin S; Gueorguieva R; Tantcheva-Poór I; Obadofin O; Camacho C; Hsi A; Kluger HH; Fadare O; Seeley EH
    J Cutan Pathol; 2020 Mar; 47(3):226-240. PubMed ID: 31697431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
    Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
    Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
    Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
    Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
    Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
    J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF
    McNeal AS; Belote RL; Zeng H; Urquijo M; Barker K; Torres R; Curtin M; Shain AH; Andtbacka RH; Holmen S; Lum DH; McCalmont TH; VanBrocklin MW; Grossman D; Wei ML; Lang UE; Judson-Torres RL
    Elife; 2021 Nov; 10():. PubMed ID: 34812139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy.
    Jackett LA; Colebatch AJ; Rawson RV; Ferguson PM; Thompson JF; McCarthy SW; Wilmott JS; Scolyer RA
    Am J Surg Pathol; 2020 Mar; 44(3):357-367. PubMed ID: 31743128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW; Kuźbicki Ł
    Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
    Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
    JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of dermoscopy and reflectance confocal microscopy for distinguishing melanomas from nevi of the breast area.
    Mandel VD; Bombonato C; Pampena R; Kyrgidis A; Borsari S; Benati E; Mirra M; Piana S; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):940-946. PubMed ID: 29125708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital computer analysis of dermatoscopical images of 260 melanocytic skin lesions; perimeter/area ratio for the differentiation between malignant melanomas and melanocytic nevi.
    Fikrle T; Pizinger K
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):48-55. PubMed ID: 17207167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.
    Valdebran M; Bandino J; Elbendary A; Gad A; Arudra KC; de Feraudy S; Elston DM
    J Cutan Pathol; 2018 Mar; 45(3):204-207. PubMed ID: 29193203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.